AstraZeneca CEO Pascal Soriot faces investor pressure to step down by Q2 2027
Resolves: Pascal Soriot announces his resignation or is forced out as CEO of AstraZeneca by 2027-06-30, confirmed by official company press release or reputable financial news outlet.
user-generated· leadership
AstraZeneca CEO Pascal Soriot faces investor pressure to step down by…
Market overview
The Wainua trial failure and broader concerns about AstraZeneca’s pipeline credibility will intensify calls for leadership change. Investor groups or major shareholders will publicly demand Soriot’s resignation by June 30, 2027, citing repeated setbacks and a loss of confidence.
leadership prediction market
- Implied probability (Yes)
- 55%
- Closes
- 2027-06-30
About this prediction
Resolution criteria
Pascal Soriot announces his resignation or is forced out as CEO of AstraZeneca by 2027-06-30, confirmed by official company press release or reputable financial news outlet.
Source: user-generated
More leadership markets
- Fried resigns as Florida Democratic Party chair — 72% Yes
- A unified Labour leadership challenger emerges by October 2027 — 60% Yes
- Bank of New York Mellon will retain Trump Accounts management through 2027 — 80% Yes
- UK PM Starmer resigns before 2027 end — 70% Yes
- Trump-endorsed candidates secure 60% of GOP wins in key redistricted seats — 60% Yes
- Kemi Badenoch resigns Conservative Party leadership post — 68% Yes
- Buttigieg endorses Michigan Senate winner — 60% Yes
- UK Conservative Party to elect new leader by 2026-12-31 — 75% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…